Elevated troponin in septic patients in the emergency department: frequency, causes, and prognostic implications

Joachim Wilhelm1, Stefan Hettwer, Markus Schuermann

  • 1Department of Medicine III, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Strasse 40, 06120, Halle (Saale), Germany, joachim.wilhelm@uk-halle.de.

Insights

Elevated cardiac troponin (cTn) is common in sepsis patients in the emergency department (ED). High-sensitive troponin T (hsTnT) levels can indicate a poor prognosis, highlighting sepsis as a key differential diagnosis.

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Emergency Medicine

Background:

  • The "Third Universal Definition of Myocardial Infarction" criteria elevate cardiac troponin (cTn) levels above the 99th percentile of a normal population.
  • Severe sepsis and septic shock frequently elevate cTn, but its role in emergency department (ED) sepsis patients is under-researched.
  • Investigating elevated high-sensitive troponin T (hsTnT) in ED sepsis patients is crucial for understanding its frequency, causes, and prognostic significance.

Purpose of the Study:

  • To determine the frequency of elevated hsTnT in emergency department (ED) sepsis patients.
  • To identify the main factors influencing hsTnT levels in sepsis.
  • To evaluate the prognostic relevance of elevated hsTnT in sepsis.

Main Methods:

  • Adult patients presenting with sepsis to the ED were enrolled.
  • High-sensitive troponin T (hsTnT) was measured upon admission.
  • Factors influencing hsTnT and its prognostic value were analyzed.

Main Results:

  • Elevated hsTnT was observed in 62.9% of 313 sepsis patients, with higher rates in severe sepsis and septic shock.
  • APACHE II score, creatinine, and coronary heart disease independently influenced hsTnT levels.
  • Elevated hsTnT showed prognostic value, with higher levels in non-survivors (AUC 0.72, p < 0.001).

Conclusions:

  • Sepsis is a significant cause of elevated cTn in the ED, necessitating its consideration in non-acute coronary syndrome (ACS) patients with positive cTn.
  • Elevated cTn in sepsis patients may serve as an indicator of adverse outcomes.
  • HsTnT elevation is frequent in sepsis, even without renal insufficiency, underscoring its role in risk stratification.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
633
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
943
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
493